Search
Close this search box.
Sydney Doctors

COVID-19 VACCINE SYDNEY CBD

Protect yourself and your family!

Help stop the spread of the virus and get your booster shot today! 

Same day appointments available

Top rated medical practice by our patients

google-logo

Google Rating

4.8
4.8/5

Sydney Doctors has been chosen to be a GP COVID 19 Vaccine Centre in Sydney CBD. We started our Vaccine roll out in April 2021 and now run daily COVID 19 Vaccination Clinics.

To book online: Sydney Doctors – Book Doctors Online with HotDoc. Then select ‘book appointment’ enter your details, when you can select an appointment type.
If you have questions about getting the COVID-19 Vaccine contact  9233 3399 . You can book online to talk to our GP about your options, choose ‘COVID-19 Vaccine Assessment’

COVID-19 Vaccine BOOSTER

For the most up-to-date details from NSW, please read here Booster vaccination – frequently asked questions – Vaccination (nsw.gov.au)

With the current ongoing circulation and transmission of SARS-CoV-2 variants namely the Omicron variant, ATAGI highly recommends a COVID-19 booster vaccination for anyone aged 16 and older who completed their primary course of COVID-19 vaccination at least 3 months ago.

A SECOND booster dose (also known as the ‘winter dose’ or ‘fourth dose’) is also recommended 3 months after your first booster dose.

Timely receipt of booster doses is particularly important for those who are immunocompromised, those who have increased exposure risk (e.g. occupational risk or outbreak areas) or those who have risk factors for severe illness from COVID-19 virus. 

Either Comirnaty (Pfizer) or Spikevax (Moderna) are recommended for use as booster vaccine, and are considered equally acceptable.

ATAGI reiterates that a third (primary) dose of COVID-19 vaccine is also recommended for anyone with immunocompromising conditions, a minimum of two months after their second dose.

FAQ

Recent studies have manifested that the immunity and effectiveness from COVID-19 vaccines begins to wane over time.

Booster vaccines strengthen your immune system and helps to maintain a high level of protection against serious illness from the COVID-19 virus for you and your loved ones.

Eligibility for the FIRST booster vaccination includes people aged 16 years and over who received their second dose of a COVID-19 vaccine 3 or more months ago. You are eligible to get a fourth dose if you are:
  • 50 years or older
  • a resident of an aged care or disability care facility
  • severely immunocompromised (this will be a fifth dose)
  • Aboriginal or Torres Strait Islander and aged 50 years and older
  • 16 years or older and with a medical condition that increases the risk of severe COVID-19 illness (see the table below for expanded groups)
  • 16 years or older with disability with significant or complex health needs or multiple comorbidities which increase risk of poor outcome.
ATAGI has advised people aged 30 to 49 years old can receive a fourth dose if they choose to. People who are immunocompromised and have received a third primary dose of a COVID-19 vaccine are highly recommended to have their booster (4th & 5th) doses.
  • For people aged 18 years and older, the Therapeutic Goods Administration (TGA) has approved the use of Pfizer or Moderna COVID-19 vaccine for the booster doses, regardless of which vaccine was used for your primary course.

    For people aged 12 – 17 years old, Pfizer COVID-19 vaccine is the only vaccine registered to be used as booster.

    Although not preferred, AstraZeneca or Novavax can be used as a booster dose when an mRNA vaccine is contraindicated or a person declines/do not prefer an mRNA vaccine.

COVID-19 Vaccine for 5-11 years old

A new formulation of the Pfizer COVID-19 vaccine (Comirnaty) has been provisionally approved for use in children aged 5-11 years by the Therapeutic Goods Administration. This approval is based on the results of a recent clinical trial demonstrating that the vaccine is highly effective and that most side effects are mild and transient. ATAGI notes that real-world evidence on the safety of this vaccine in children aged 5-11 years is rapidly accumulating overseas, including data on the low rate of rare adverse events following immunisation, notably myocarditis, which the clinical trial was insufficiently powered to assess.

ATAGI’s recommendations take into account:

  • The direct benefits of vaccination for the child in preventing illness;
  • The indirect benefits of vaccination for the child, their family and for the broader community. To realise some of these benefits, a large proportion of the 5-11 year age group would need to be vaccinated;
  • Adequate supply of the paediatric Pfizer COVID-19 vaccine is expected to be available to vaccinate all 5-11-year-old children.

Eligibility

  • ATAGI recommends vaccination with the paediatric Pfizer COVID-19 vaccine for all children aged 5-11 years.
  • Children aged 5-11 years with medical risk factors for severe illness, Aboriginal and Torres Strait Islander children, and children living in crowded conditions or outbreak areas are most likely to benefit from COVID-19 vaccination given their increased risk of severe outcomes and/or exposure.
  • Children aged 5-11 years who have previously had SARS-CoV-2 infection should wait 3 months before receiving the paediatric Pfizer COVID-19 vaccine. This is to optimise their vaccine protection as a longer interval between infection and vaccination is likely to lead to a better immune response and result in longer protection from reinfection. The next scheduled dose of COVID-19 vaccine should be administered as soon as possible after 3-month gap. Your child should still have all the recommended doses.
  • If your child has had COVID-19 infection, they do not need to defer other vaccinations, for example flu vaccine. BUT they should not be receiving any vaccines if they are acutely unwell (e.g. having a fever).
  • The recommended schedule for vaccination in this age group is 2 doses, 8 weeks apart. The interval can be shortened in special circumstances to a minimum of 3 weeks, such as in an outbreak response, prior to the initiation of significant immunosuppression or international travel.

FAQ

How will boosters be rolled out? Booster vaccination is offered to everyone over 16 years old who had completed their primary course of COVID-19 vaccine at least three months ago. If you received your last primary dose of COVID-19 vaccine over 3 months ago, you should receive your booster shot as soon as possible. However if you have had COVID-19, you should wait for 3 months after your confirmed infection before receiving your COVID-19 vaccine booster dose An additional booster, or fourth dose (also known as ‘winter dose’) is recommended for people with increased risk of severe illness, to be given 3 months after their first booster dose. This additional dose will be a fifth dose for people who are severely immunocompromised. To be eligible for this fourth dose of COVID-19 vaccine, you should be:
  • 50 years or older
  • 16 years or older and a resident of an aged care or disability care facility
  • 16 years or older and severely immunocompromised
  • Aboriginal or Torres Strait Islander and aged 50 years and older
  • 16 years or older with a medical condition that increases the risk of severe COVID-19 illness
  • 16 years or older with a disability.
ATAGI also advised that people aged 30-49 years old can receive a fourth dose if they choose to. For more information, please refer to COVID-19 booster vaccine advice

You can check your immunisation record or COVID-19 vaccination certificate for the date of your second vaccination dose.

You may also be contacted through SMS or email to let you know you are eligible for a booster vaccination based on the time since your last primary course dose.

Your third dose helps to build an immune response similar to people who are not immunosuppressed. Those who are immunocompromised and have had/are having a third primary dose of a COVID-19 vaccine are recommended to have a booster dose (first booster). An additional second booster dose, also known as the ‘winter booster dose’, could be given at least 4 months or more from the first booster dose OR from 3 months after a confirmed SARS-CoV-2 infection, if infection happened since the person’s first COVID-19 booster dose. Further advice on boosters in this group could be found at COVID-19 booster vaccine advice
A primary course of a vaccine is the number of doses it takes to achieve a good level of protection against a disease.
  • For the COVID-19 vaccines available in Australia, a primary course is two doses for most people.
  • For people who received a recognised overseas vaccine, a primary course could be one or two doses, depending on the type of vaccine.
  • For some people who are immunocompromised due to certain treatments or conditions, a third dose is recommended as part of a primary course to achieve similar levels of protection.
A booster is an extra dose of a vaccine, given sometime after the primary course. It ‘boosts’ the immune system and helps to maintain a high level of protection from the disease.
  • You may be familiar with other vaccines that have booster shots, such as tetanus and whooping cough (pertussis).
For further information regarding booster doses, please refer to COVID-19 booster vaccine advice
For the purposes of complying with public health orders, you are considered fully vaccinated if you have two doses of an approved vaccine. Booster shots are not required for compliance with public health orders. However to be considered ‘up to date’ with COVID-19 vaccination, you must have had all the doses recommended for your age and health needs. This booster dose is now recommended from 3 months after the last primary dose. This is called the ‘due date’. You will no longer be considered ‘up to date’ and will instead be considered ‘overdue’ if you have not had a booster dose in the recommended timeframe for your age or health status. For more information, please refer to Staying up to date with COVID-19 vaccination
COVID-19 booster vaccines are not mandatory but are highly recommended to help maintain the best possible protection against the virus. If you’re eligible for a booster, but have not had one within 6 months, you will no longer be ‘up to date’ with your vaccinations and be considered as ‘overdue’. Some high-risk workplaces would require employees to receive COVID-19 booster vaccines. This includes places where workers look after vulnerable people. Please refer to vaccination requirements for workers for more information.
Booster doses are recommended for all pregnant women aged 16 years or older who have received their last dose of their primary course of COVID-19 vaccination at least 3 months ago. The Pfizer vaccine is the preferred vaccine for pregnant women. For more information, refer to the ATAGI clinical guidance.

Experts all over the world are tracking and researching the COVID-19 virus to better understand how long the vaccines will provide protection against COVID-19, as well as how well they protect against new variants of the virus as they emerge.

This evidence will help to inform whether further boosters will be needed in the future.

Waiting for your Vaccine

While waiting for the vaccine continue to protect yourself and your family against COVID-19. Whether you are vaccinated or not, there are things you can do to protect yourself and others from COVID-19. You must:

Who will receive a vaccine?

Everyone in Australia will be offered a safe and effective COVID-19 vaccine.

The Australian Technical Advisory Group on Immunisation (ATAGI) gave advice to the Government on prioritising groups for COVID-19 vaccination.

COVID-19 vaccines will be voluntary

The COVID-19 vaccine will be voluntary and free. As safe and effective vaccines become available the Government will vaccinate as many Australians as possible for COVID-19.

If you choose not to have a COVID-19 vaccine your eligibility for Government payments won’t be affected.